When Finishing Early Is Worth Seeing a Doctor About

Most men never raise this with a doctor, and for a sizeable share of them that is a genuine missed opportunity — not because there is a wonder drug, but because a specific, findable, reversible cause exists more often than people expect.

The question that decides everything

The AUA/SMSNA guideline splits premature ejaculation into two conditions, and treats them differently from the first appointment.

Lifelong PE — present since you became sexually active. Here the guideline says additional testing is not recommended. There is no hidden cause to find, and investigating further mostly generates anxiety and bills.

Acquired PE — a latency markedly reduced from what you used to experience. Here the guideline says additional testing may be used as clinically indicated. Something changed, and it is reasonable to ask what.

If you take one thing from this page: new is worth investigating, lifelong usually is not.

What new-onset PE can be a sign of

The erectile dysfunction link deserves a note, because the relationship runs in both directions. A man who is struggling to keep an erection may unconsciously rush to finish before he loses it, which looks exactly like premature ejaculation. Equally, a man managing early ejaculation by damping down his own arousal can end up with erection problems. Which came first genuinely changes what should be treated.

What the appointment actually involves

Less than most men fear. The guideline sets out a clinical principle that assessment consists of a medical, relationship and sexual history, together with a focused physical examination. Validated questionnaires may be used to help with diagnosis, though that is a weaker, Grade C recommendation.

For lifelong PE, that is the end of it — no bloods, no scans. For acquired PE, testing follows whatever the history points at, which in practice often means thyroid function and an assessment for prostatitis or erectile dysfunction rather than a broad panel.

There is no test for premature ejaculation itself. The diagnosis is made from what you describe.

The prescription options

The guideline’s first-line recommendation is a strong one, Grade B, and it covers three things: daily SSRIs, on-demand clomipramine or dapoxetine where available, and topical penile anaesthetics.

Daily SSRIs. Delayed ejaculation is a well-known side effect of this class of antidepressant, and here it is the intended effect. In the US these are prescribed off-label for this purpose — meaning the drug is approved, but not specifically for this use. That is legal, common, and not a red flag.

Topical anaesthetics. In a phase III trial across 32 centres, 300 men were randomised to a lidocaine-prilocaine spray or placebo. Geometric mean latency reached four minutes on the spray against one minute on placebo, and only 2.6% of patients reported a treatment-related adverse event. The practical consideration these trials raise is transfer — the anaesthetic does not distinguish between you and your partner, which is why timing, washing off, or a condom tends to feature in the instructions.

Dapoxetine. Worth being precise about: dapoxetine is not approved by the FDA and is not legally available in the United States. It is approved in a number of other countries. If a website is offering to ship you Priligy in the US, it is selling an unapproved drug, and you have no assurance about what is in it.

Alpha-blockers appear in the guideline for men who have failed first-line treatment, but as expert opinion only — the panel had no trial evidence to point to.

Tramadol, and why it is second-line

Tramadol is recommended on demand for men who have failed first-line therapy, and only as a conditional, Grade C recommendation. It works, modestly. It also deserves more caution than it usually gets.

A meta-analysis of four randomised trials covering 721 men found tramadol added a mean of 1.24 minutes of latency over placebo, with a confidence interval running from 0.52 to 1.95 minutes. Statistical heterogeneity between the trials was high, which means the studies disagreed with one another more than you would like.

Adverse events were significantly more common than with placebo or behavioural therapy, and included erectile dysfunction, nausea, constipation, drowsiness, dizziness and headache. Erectile dysfunction as a side effect of a treatment for premature ejaculation is a genuinely awkward trade.

The most important line in that review is what was not studied. The authors state that addiction problems and breathing difficulties in men taking tramadol for premature ejaculation have not been assessed in the existing evidence, and that long-term effects including addiction potential have not been evaluated. Tramadol is an opioid. An unstudied addiction risk is not the same thing as a low one.

The referral most men do not expect

The guideline recommends that clinicians consider referring men with premature ejaculation to a mental health professional with expertise in sexual health — a moderate recommendation.

This is not a polite way of saying the problem is imaginary. It reflects the finding that combining behavioural and pharmacological treatment is more effective than either alone, which is itself a moderate, Grade B recommendation. The referral is part of the treatment, not a substitute for it. More on that in breathing, focus and the performance anxiety loop.

How to raise it

You do not need a script, but two pieces of information make the appointment far more productive, and both are things only you can supply.

The first is whether this is lifelong or new — and if new, roughly when it changed and what else was going on at the time. The second is whether your erections are reliable, because that single answer redirects the whole consultation.

It is also reasonable to say that you would like your thyroid checked if this is new. That is not an unusual request, and it is directly supported by the evidence above.

If you are still not sure whether what you are experiencing meets the definition at all, start here.

This article is for information only and is not medical advice. It cannot account for your individual circumstances. Talk to a doctor about your own situation, particularly before starting or stopping any prescription medication.